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Abstract 
Ca2+/calmodulin-dependent protein kinase kinase β (CaMKKβ) acts as a regulatory kinase that 
phosphorylates and activates multiple downstream kinases including CaMKI, CaMKIV, 5’AMP-activated 
protein kinase (AMPK) and protein kinase B (PKB), resulting in regulation of wide variety of 
Ca2+-dependent physiological responses under normal and pathological conditions. CaMKKβ is regulated 
by Ca2+/calmodulin-binding, autophosphorylation, and transphosphorylation by multiple protein kinases 
including cAMP-dependent protein kinase (PKA). In this report, we found that phosphorylation of 
CaMKKβ is dynamically regulated by protein phosphatase/kinase system in HeLa cells. Global 
phosphoproteomic analysis revealed the constitutive phosphorylation at 8 Ser residues including Ser128, 
132, and 136 in the N-terminal regulatory domain of rat CaMKKβ in unstimulated HeLa cells as well as 
inducible phosphorylation of Thr144 in the cells treated with a phosphatase inhibitor, okadaic acid (OA). 
Thr144 phosphorylation in CaMKKβ has shown to be rapidly induced by OA treatment in a time- and 
dose-dependent manner in transfected HeLa cells, indicating that Thr144 in CaMKKβ is maintained 
unphosphorylated state by protein phosphatase(s). We confirmed that in vitro dephosphorylation of 
pThr144 in CaMKKβ by protein phosphatase 2A and 1. We also found that the pharmacological inhibition 
of protein phosphatase(s) significantly induces CaMKKβ-phosphorylating activity (at Thr144) in HeLa cell 
lysates as well as in intact cells; however, it was unlikely that this activity was catalyzed by previously 
identified Thr144-kinases, such as AMPK and PKA. Taken together, these results suggest that the 
phosphorylation and dephosphorylation of Thr144 in CaMKKβ is dynamically regulated by multiple 
kinases/phosphatases signaling resulting in fine-tuning of the enzymatic property. 
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1. Introduction 
Ca2+/calmodulin-dependent protein kinase kinases (CaMKKs) are known as activators for multiple protein 
kinases including CaMKI, CaMKIV, protein kinase B (PKB/Akt) and 5’AMP-activated protein kinase (AMPK) 
that phosphorylate the activation loop Thr residues to activate their catalytic efficiencies, resulting in the 
regulation of various physiological responses mediated by intracellular Ca2+ including neuronal, 
metabolic, and pathophysiological pathways [1-5]. CaMKK is composed of two isoforms (α and β) in 
mammals [6-8]. Previous studies demonstrated that CaMKKβ activates AMPK through phosphorylation 
of Thr172 in AMPKα, resulting in various metabolic and pathophysiological responses [9-11]. Especially, 
CaMKKβ-mediated signaling pathways are involved in cell growth of various cancers such as prostate [12], 
ovarian [4], and lung cancers [13] as well as in nonalcoholic fatty liver disease [14]. Similarly to other 
CaMKs, CaMKK is regulated by autoinhibitory mechanism and activated by Ca2+/CaM-binding [15]. In 
addition to Ca2+/CaM-binding, it has been demonstrated that CaMKKα is negatively regulated by 
phosphorylation with cAMP-dependent protein kinase (PKA), resulting in the recruitment of 14-3-3 
proteins [16-18]. In contrast to CaMKKα, recombinant CaMKKβ has shown to be partially constitutively 
active because the N-terminal regulatory domain (NRD, residues 129-151) prevents the autoinhibitory 
mechanism of the enzyme [19]. It has been demonstrated that the phosphorylation of Ser129, Ser133, 
and Ser137 in the NRD of human CaMKKβ by cyclin-dependent kinase 5 (CDK5) and glycogen synthase 
kinase 3 (GSK3) reduced autonomous activity [20]. Moreover, feedback phosphorylation of Thr144 in the 
same region by activated AMPK converts CaMKKβ into a Ca2+/CaM-dependent enzyme [21], indicating 
that phosphorylation of the NRD suppresses the inhibitory effect of the region in the autoinhibitory 
mechanism. Recently, we have demonstrated that Thr144 in CaMKKβ is also rapidly phosphorylated by 
β-adrenergic stimulation through cAMP/PKA signaling; this has been confirmed by in vitro 
phosphorylation of Thr144 by purified PKA [22].  
In this study, we found that Thr144 in CaMKKβ is strictly maintained in the dephosphorylated state by 
protein phosphatases in resting HeLa cells and is phosphorylated by okadaic acid (OA)-activated protein 
kinase(s). 
 
2. Materials and Methods 
2.1. Materials 
Recombinant rat CaMKKβ was expressed in E. coli BL21 Star (DE3) cells by using pET- rat CaMKKβ and 
purified by CaM-Sepharose and Q-Sepharose chromatography. pME-GST-rat CaMKKβ was constructed by 
PCR amplification of GST-rat CaMKKβ using pGEX-PreS-CaMKKβ [19] as a template, followed by 
subcloning into pME18s vector. Anti-phospho-CaMKKβ at Thr144 (clone A04) monoclonal antibody was 
generated as previously described [21]. Anti-CaMKKβ antibody was generated as previously described 
[23]. The catalytic subunit of cAMP-dependent protein kinase from bovine cardiac tissue was kindly 
provided by Dr. Yasuo Watanabe (Showa Pharmaceutical University). Okadaic acid was obtained from 
Wako Pure Chemical Industries (Osaka, Japan). Compound C and H-89 was purchased from Tokyo 
Chemical Industry Co., Ltd. (Tokyo, Japan) and Cayman Chemical (Michigan, USA), respectively. Protein 
phosphatase 1 (#P7937) and protein phosphatase 2A (#14-111,) were purchased from Sigma-Aldrich (St. 
Louis, MO) and Upstate (Lake Placid, NY), respectively. All other chemicals were obtained from standard 
commercial sources. 
 
2.2. Cell culture and transfection 
HeLa cells were cultured in 6-well dishes or 10-cm dishes containing Dulbecco’s modified Eagle’s medium 
supplemented with 10% fetal bovine serum at 37 oC in 5% CO2. HeLa cells in 6-well dishes were 
transfected with 2 µg (pME-CaMKKβ) expression plasmid using polyethylenimine “MAX” (Polysciences, 
Inc. Warrington, PA) according to the manufacturer’s protocol. After 48-h culture, the cells were cultured 
with or without indicated concentrations of protein kinase inhibitors for 30 min, followed by treatment 
with okadaic acid for indicated time periods. Then, the cells were extracted with either 100 µL of lysis 
buffer (150 mM NaCl, 20 mM Tris-HCl pH 7.5, 2 mM EDTA, 2 mM EGTA, 1% NP40, 10% Glycerol, 1:1000 
protease inhibitor mixture (Nacalai Tesque, Kyoto Japan) or 1u SDS-PAGE sample buffer (100 µL), 
followed by immunoblot analyses (5–10 µL cell lysates).  
 
2.3. Identification of phosphorylation sites in CaMKKβ by LC-MS/MS analysis. 
HeLa cells in 10-cm dishes were transfected with 10 µg of GST-CaMKKβ (pME-GST-CaMKKβ) expression 
plasmid expressing and subsequently treated with 0.5 µM OA for 1 h, followed by washing with ice-cold 
PBS and, subsequently, extracted with 1 mL of ice-cold lysis buffer (150 mM NaCl, 20 mM Tris-HCl pH 7.5, 
and 0.05% Tween20). Cell lysates were subjected to purification with glutathione-sepharose resin (25 µL 
gel volume) and GST-CaMKKβ was eluted by addition of 1u SDS-PAGE sample buffer (50 µL) followed by 
subjecting to SDS-10% PAGE analysis. Lightly stained bands corresponding to GST-CaMKKβ (see Fig. 1A) 
on the gel were excised and subjected to protease digestion with a protease or protease mixture, 
including trypsin (Promega, Madison, USA), chymotrypsin (Roche Diagnostics GmbH, Mannheim, 
Germany), Glu-C (Roche Diagnostics GmbH), elastase (Promega), trypsin with Asp-N (Roche Diagnostics 
GmbH), trypsin with chymotrypsin, trypsin with Glu-C or chymotrypsin with Asp-N. The following 
protease concentrations were used: 10 µg/mL trypsin, 17 µg/mL chymotrypsin, 10 µg/mL Glu-C, 4 µg/mL 
Asp-N, and 100 µg/mL elastase. Trypsin, Asp-N, and elastase were incubated at 37 °C, and chymotrypsin 
and Glu-C were incubated at 25 °C. The first and second digestions were incubated overnight and for 3 h, 
respectively. The digested peptides were analyzed by LC-MS/MS to identify the phosphorylation sites 
using an LCMS-IT-TOF instrument (Shimadzu, Kyoto, Japan) interfaced with a nano reverse-phase LC 
system (Shimadzu), as previously described [21]. The MS/MS data were acquired in the 
datum-dependent mode using the LC-MS solution software (Shimadzu) and converted into a single text 
file (containing the observed precursor peptide m/z, fragment ion m/z, and intensity values) using the 
Mascot Distiller (Matrix Science, London, UK). The MS/MS data were obtained independently and 
merged for the Mascot analysis (Supplemental figure S1). The following search parameters were used: 
database, rat CaMKKβ (587 amino acid residues); enzyme, all; variable modifications, carbamidomethyl 
(Cys), oxidation (Met), and phosphorylation (Ser/Thr). 
 
2.4. Protein phosphatase assay 
Recombinant CaMKKβ (293 µg) was phosphorylated with purified PKA (1µg) at 30 oC for 240 min as 
described previously [22], followed by purification with CaM-sepharose column chromatography, 
resulting in approximately 160 µg of phosphorylated CaMKKβ. Phosphorylated CaMKKβ (80 µg/mL) was 
incubated without or with protein phosphatase 2A (4.6 µg/mL) or protein phosphatase 1 (5–50 µg/mL) 
in a solution containing 40 mM Tris-HCl pH 7.5, 100 mM KCl, 3 mM MgCl2, 1 mM DTT, and 0.1 mg/mL 
bovine serum albumin in the absence (for PP2A) or presence of 2 mM MnCl2 (for PP1) at 30 oC for the 
indicated time periods. Reactions were terminated by addition of an equal volume of 2× SDS-PAGE buffer, 
followed by immunoblot analysis. 
 
2.5. In vitro Thr144-phosphorylation assay  
HeLa cells in 6-well dishes was treated with 0.5 µM OA for indicated time periods, washed with ice-cold 
PBS and subsequently lysed with 50 µL of lysis buffer as described in 2.2. Recombinant CaMKKβ (1 µg) 
was incubated with 5 µL of HeLa cell extracts or purified catalytic subunit of PKA (10 ng) in a solution (20 
µL) containing 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 100 µM ATP, and 100 nM OA in the 
absence or presence of protein kinase inhibitors at 30 oC for 30 min (10 min for PKA). The reaction was 
terminated by addition of an equal volume of 2× SDS-PAGE buffer, followed by immunoblot analysis 
using either anti-CaMKKβ or anti-pThr144 antibody. 
 
2.6. Other methods 
Immunoblot analysis was performed with the indicated primary antibodies and horseradish 
peroxidase-conjugated anti-mouse IgG or anti-rabbit IgG (GE Healthcare UK, Ltd.) as the secondary 
antibody. A chemiluminescent reagent (PerkinElmer Life Sciences, Waltham, MA, USA) was used for 
signal detection of immunoblots, followed by quantification of the immunoreactivity with ImageJ 
software [24]. Protein concentrations in samples were estimated by Coomassie Brilliant Blue (Bio-Rad 
Laboratories, Inc.), using bovine serum albumin as a standard.  
 
 
3. Results and Discussion 
3.1. Global phosphorylation of CaMKKβ in HeLa cells 
CaMKKβ has shown to be regulated by phosphorylation with multiple protein kinases in the NRD 
(residues 129–151, [19]) by GSK3 and CDK5 [20] and in the C-terminal region (at S511 in human 
CaMKKβ) by death-associated kinase (DAP kinase) [25] in transiently overexpressed cultured cells as well 
as in vitro. Recently, we identified Thr144 in the NRD of rat CaMKKβ by AMPK [21] and cAMP/PKA 
signaling in transiently expressed HeLa cells [22]. It has been shown that the Thr144 phosphorylation 
converts CaMKKβ into Ca2+/CaM-dependent enzyme [21,22]. These studies also indicated that the 
Thr144 phosphorylation was very weak without stimulation, suggesting that the Thr144 is maintained 
unphosphorylated by protein phosphatase(s) in resting cells. Here, in order to examine the global 
Ser/Thr phosphorylation profile of CaMKKβ in intact cells, HeLa cells expressing GST-rat CaMKKβ were 
treated with 0.5 µM of a protein phosphatase inhibitor, okadaic acid (OA) for 1 hr (Fig. 1A) and then 
phosphorylation sites of purified GST-CaMKKβ were compared with those of untreated cells determined 
by LC-MS/MS analysis (Fig.1 C and Supplemental Figure S1). In the presence and absence of OA 
treatment, one phospho-Ser residue at N-terminal region (Ser22), three phosphorylation sites (Ser128, 
Ser132, Ser136) in the NRD, phospho-Ser494 in CaM-binding site and three phosphorylation sites 
(Ser510, Ser545, Ser571) in the C-terminal region were identified, indicating CaMKKβ is constitutively 
phosphorylated at multiple residues (Supplemental Figure S1) [20]. Furthermore, we found that OA 
treatment induces additional phosphorylation at Thr144 (Figure 1B, Supplemental Figure S1). These 
results are consistent with previous reports demonstrating that human CaMKKβ is phosphorylated at 
Ser129, Ser133, and Ser137 by CDK5/GSK3 in transiently overexpressed COS-7 cells [20] and Ser511 in 
SH-SY5Y cells by DAPK [25] and Thr144 is maintained unphosphorylated state in unstimulated HeLa cells 
[21,22]. 
 
3.2. Phosphorylation of CaMKKβ at Thr144 in HeLa cells by okadaic acid treatment  
To confirm the involvement of protein phosphatase(s) and kinase(s) in the regulation of CaMKKβ 
phosphorylation status, we analyzed the effect of OA on the Thr144 phosphorylation in transiently 
expressing rat CaMKKβ in HeLa cells by immunoblot analysis using an anti-pThr144 antibody. Thr144 
phosphorylation of CaMKKβ was significantly induced by OA-treatment in a concentration-dependent 
(Fig. 2A) and a time-dependent (Fig. 2B) manner in transfected HeLa cells. This result is consistent with 
the fact that Thr144 phosphorylation is maintained at low level by dephosphorylation and rapidly 
induced by endogenous protein kinase(s) in HeLa cells. Previous studies demonstrated that the activated 
AMPK and PKA were capable of phosphorylating Thr144 in CaMKKβ in vitro as well as in cultured cells 
[21,22]. Therefore, we examined whether OA-induced Thr144 phosphorylation of CaMKKβ in the cells 
was catalyzed by AMPK or PKA by using pharmacological inhibitors (compound C, AMPK inhibitor and 
H-89, PKA inhibitor). As shown in Fig. 2C, treatment with 10 µM compound C did not significantly affect 
OA-induced Thr144 phosphorylation of CaMKKβ in HeLa cells (approximately 20% inhibition), indicating 
that AMPK is unlikely to be responsible for the Thr144 phosphorylation in the cells. In contrast, 10 µM 
H-89 treatment exhibited approximately 70% inhibition of the OA-induced CaMKKβ phosphorylation. 
Consistent with this result, dose-dependent effect of H-89 on the CaMKKβ phosphorylation in HeLa cells 
(Fig. 2D) indicated that 10 µM H-89 treatment exhibited approximately 60% inhibition of OA-induced 
Thr144 phosphorylation of CaMKKβ but 1 µM H-89 did not affect the phosphorylation (IC50 = 8 µM).  
 
3.3. Induction of CaMKKβ phosphorylation activity in HeLa cells by okadaic acid treatment 
To characterize the kinase activity in HeLa cells responsible for OA-induced Thr144 phosphorylation of 
CaMKKβ, we incubated the extracts of HeLa cells, which is treated or not treated with 0.5 µM OA for 
various time points, with recombinant CaMKKβ in the presence of Mg-ATP, followed by analysis of 
Thr144 phosphorylation activity by immunoblotting using an anti-pThr144 antibody. As shown in Fig. 3A, 
Thr144-phosphorylating activity in HeLa cell extracts was shown to be weak in untreated cells, which 
were significantly induced by OA-treatment. This indicates that the CaMKKβ-kinase is activated by 
OA-treatment suggesting that the kinase is downregulated by protein phosphatase(s). This result is in 
good agreement with the OA-induced phosphorylation at Thr144 in CaMKKβ in HeLa cells (Fig. 2A and B). 
Treatment of HeLa cells with compound C and H-89 as shown in Fig. 2C and D suggested that the 
OA-induced Thr144 phosphorylation in HeLa cells is catalyzed by H-89 sensitive kinases but it unlikely 
that AMPK catalyzes Thr144 phosphorylation. Therefore, we tested the effect of H-89 on the OA-induced 
Thr144-phosphorylation activity in HeLa cell extracts. As shown in Fig. 3B, H-89 up to 1 µM was 
incapable of inhibiting CaMKKβ-kinase activity in HeLa cell lysate and 10 µM of H-89 exhibited 
approximately 60% inhibition with an IC50 value of 9 µM, consistent with the effect of H-89 on 
OA-induced CaMKKβ Thr144 phosphorylation in HeLa cells as shown in Fig. 2C and D. To test whether 
the H-89 sensitive CaMKKβ-kinase in HeLa cell extracts is identical to PKA, we examined the effect of 
H-89 on the phosphorylation of CaMKKβ at Thr144 by purified PKA catalytic subunit (Fig. 3B insert). In 
contrast to the effect of H-89 on OA-induced CaMKKβ-kinase activity in HeLa cell extracts as shown in Fig. 
3B, PKA activity was completely inhibited by 1 µM of H-89 with an IC50 value of 0.5 µM, which was 
>10-fold more sensitive to H-89 than the OA-induced CaMKKβ-kinase activity in HeLa cells. It is 
noteworthy that compound C was incapable of inhibiting the CaMKKβ-kinase activity in HeLa cell 
extracts up to 10 µM (Supplemental Figure S2). These results indicate that the pharmacological 
inhibition of protein phosphatase(s) induces the CaMKKβ-phosphorylating activity (at Thr144) in HeLa 
cell lysates as well as in intact cells; however, it was unlikely that this activity was catalyzed by previously 
identified Thr144-kinases such as AMPK and PKA [21,22]. 
 
3.4. Dephosphorylation of CaMKKβ at Thr144 in vitro 
Finally, to confirm the dephosphorylation of Thr144 in CaMKKβ by OA-sensitive protein phosphatases, in 
vitro dephosphorylation assay of CaMKKβ by protein phosphatase 2A (PP2A, Fig. 4A) and protein 
phosphatase 1 (PP1, Fig. 4B) was performed. By using recombinant CaMKKβ that had been 
phosphorylated at Thr144 by PKA [22] as a substrate, both protein phosphatases were capable of 
dephosphorylating Thr144 in CaMKKβ. It is noteworthy that the complete dephosphorylation of Thr144 
within 60 min requires 10 times higher amount of PP1 (50 µg/mL, Fig. 4 B) than PP2A (4.6 µg/mL, Fig. 
4A).  
In this report, we found that Thr144 in CaMKKβ was strictly maintained in the dephosphorylated state in 
HeLa cells and phosphorylated by H-89 sensitive protein kinase(s) that were activated by 
pharmacological inhibition of the protein phosphatase activity in the cells whereas multiple Ser residues 
are constitutively phosphorylated in the cells. H-89 was reported not to be a specific inhibitor for PKA 
but capable of inhibiting multiple protein kinases including mitogen- and stress-activated protein kinase 
1, p70 ribosomal protein S6 kinase 1 and Rho-dependent protein kinase II [26]. Therefore, our 
pharmacological analyses suggest that it is unlikely that AMPK or PKA are responsible for OA-induced 
Thr144 phosphorylation in HeLa cells, even though these proteins were previously identified as CaMKKβ 
(Thr144) kinases [21,22]. Previous studies demonstrated that the Thr144 phosphorylation converted 
CaMKKβ into Ca2+/CaM-dependent enzyme [21,22]. Taken together, these results may indicate that 
CaMKKβ is dynamically regulated by phosphorylation/dephosphorylation at Thr144 in the cells to 
fine-tune the enzymatic regulation. 
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Figure Legends 
Figure 1. Phosphorylation profile of rat CaMKKβ expressed in HeLa cells. A. GST-CaMKKβ (rat) expressed 
in HeLa cells that were treated (+) or not treated (−) with 0.5 µM okadaic acid (OA) for 1 h was partially 
purified by glutathione-sepharose resin as described in the “Materials and Methods”, followed by 
SDS-PAGE analysis (25 µL each sample). Subsequently, protein bands corresponding to GST-CaMKKβ 
(arrow) were excised and subjected to LC-MS/MS analysis. The molecular mass in kDa is indicated on the 
left. B. The phosphorylation of Thr144 was analyzed through LC-MS/MS of the singly charged ion for 
peptides containing residues 142–148. The observed b- and y-ion fragment series generated by 
collision-induced dissociation are indicated above and below the peptide sequences (see Supplemental 
Figure S1). C. Schematic representation of the phosphorylation sites identified by LC-MS/MS analysis 
(see Supplemental Figure S1) in GST-CaMKKβ (rat) expressed in HeLa cells that were treated (+) or not 
treated (−) with 0.5 µM okadaic acid for 1 h as shown in panel A. NRD, N-terminal regulatory domain; 
AID/CaM, autoinhibitory and calmodulin-binding domain. 
 
Figure 2. Induction of Thr144 phosphorylation in CaMKKβ expressed in HeLa cells by okadaic acid (OA) 
treatment. HeLa cells transfected with rat CaMKKβ expression vector were treated with various 
concentrations (0–0.5 µM) of OA for 1 h (A) or 0.1 µM of OA for the indicated time periods (B). HeLa cells 
transfected with rat CaMKKβ expression vector were incubated without (−) or with (+) 10 µM of 
compound C (CC) or 10 µM of H-89 (C) or with various concentrations (0–50 µM) of H-89 (D) for 30 min, 
and subsequently treated with 0.5 µM OA for 1h. After lysis of the cells with 1× SDS-PAGE sample buffer 
(100 µL), 10 µL of the cell lysates (duplicate) were subjected to immunoblot analysis using either 
anti-phosphoThr144 antibody or anti-CaMKKβ antibody. The phosphorylation level of CaMKKβ at Thr144 
was quantitated as duplicate experiments (A, B, C) and expressed as a percentage of the average value of 
the cells treated with 0.5 µM OA for 1 h without kinase inhibitors (A, C, D) or 0.1 µM OA for 5 h (B). C 
insert; (1) −OA, (2) + 0.5 µM OA, (3) + 0.5 µM OA, + 10 µM compound C (CC), (4) + 0.5 µM OA, + 10 µM 
H-89, (5) + 0.5 µM OA, + 10 µM CC/H-89. Arrows (pThr144) in insert panels (A, B) and asterisks in insert 
panels (C, D) indicate phosphoCaMKKβ (at Thr144). Asterisks in insert panels (A, B) indicate CaMKKβ. The 
molecular mass in kDa is indicated on the left (insert panels). The data are representative of at least two 
independent experiments.  
 
Figure 3. CaMKKβ phosphorylation (at Thr144) activity in HeLa cells. A. Lysates of HeLa cells that were 
not treated (0 min) or treated with 0.5 µM of okadaic acid (OA) for indicated time periods (10–90 min) 
were incubated with recombinant CaMKKβ (1 µg) in the presence of Mg-ATP for 30 min, followed by 
immunoblot analysis for detection of Thr144 phosphorylation (upper panel) and CaMKKβ (lower panel). 
The phosphorylation level of CaMKKβ at Thr144 was quantitated as duplicate experiments and expressed 
as a percentage of the average value of phosphorylated CaMKKβ with OA-treatment for 60 min. B. 
Lysates of HeLa cells treated with 0.5 µM of OA for 60 min or catalytic subunit of PKA (insert panel, 
Supplemental Figure S3) were assayed for CaMKKβ kinase activity as described in panel A in the presence 
of various concentrations (0–10 µM) of H-89. Thr144 phosphorylation activities were detected by 
immunoblot analysis using anti-pThr144 antibody (upper panel), quantitated as duplicate experiments 
and expressed as a percentage of the average value in the absence of H-89. Arrows (pThr144) indicate 
phosphoCaMKKβ (at Thr144). The molecular mass in kDa is indicated on the left (upper panels). The data 
are representative of at least two independent experiments. 
 
Figure 4. Dephosphorylation of Thr144 in CaMKKβ by protein phosphatases. A. Recombinant CaMKKβ 
phosphorylated by PKA was incubated without (−PP2A, 0 min) or with protein phosphatase 2A (+PP2A) 
for indicated time periods (5–60 min) followed by terminating the reaction by addition of 2x SDS-PAGE 
sample buffer as described in the “Materials and Methods”. B. Recombinant CaMKKβ phosphorylated by 
PKA was incubated without (0 µg) or with indicated amount of protein phosphatase 1 (5–50 µg) for 60 
min followed by terminating the reaction as described in panel A. Reaction mixture (10 µl) were 
subjected to immunoblot analysis using either an anti-phosphoThr144 antibody (upper panels) or 
anti-CaMKKβ antibody (lower panels). The phosphorylation level of CaMKKβ at Thr144 was quantitated 
as duplicate experiments and expressed as a percentage of the average value of phosphorylated CaMKKβ 
without protein phosphatase treatment. Arrows (pThr144) in upper panels (A, B) indicate 
phosphoCaMKKβ (at Thr144). The molecular mass in kDa is indicated on the left (upper panels). The data 
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